Blood-based biomarkers in the oldest old: towards Alzheimer's disease detection in primary care.
作者信息
Contador José, Suárez-Calvet Marc
机构信息
Barcelonaβeta Brain Research Center (BBRC), Pasqual Maragall Foundation, Barcelona, Spain.
Servei de Neurologia, Hospital del Mar, Barcelona, Spain.
出版信息
Lancet Reg Health Eur. 2024 Sep 19;45:101077. doi: 10.1016/j.lanepe.2024.101077. eCollection 2024 Oct.
Abstract
摘要
相似文献
1
Blood-based biomarkers in the oldest old: towards Alzheimer's disease detection in primary care.高龄老人血液中的生物标志物：迈向初级保健中阿尔茨海默病的检测
Lancet Reg Health Eur. 2024 Sep 19;45:101077. doi: 10.1016/j.lanepe.2024.101077. eCollection 2024 Oct.
2
Biomarkers for Early Diagnosis of Alzheimer's Disease in the Oldest Old: Yes or No?老年人群中阿尔茨海默病早期诊断的生物标志物：是与否？
J Alzheimers Dis. 2017;58(2):323-335. doi: 10.3233/JAD-161127.
3
Prognostic value of Alzheimer's disease plasma biomarkers in the oldest-old: a prospective primary care-based study.阿尔茨海默病血浆生物标志物在高龄老人中的预后价值：一项基于初级保健的前瞻性研究。
Lancet Reg Health Eur. 2024 Aug 16;45:101030. doi: 10.1016/j.lanepe.2024.101030. eCollection 2024 Oct.
4
Tau biomarkers in Alzheimer's disease: towards implementation in clinical practice and trials.阿尔茨海默病中的 Tau 生物标志物：迈向临床实践和试验的应用。
Lancet Neurol. 2022 Aug;21(8):726-734. doi: 10.1016/S1474-4422(22)00168-5. Epub 2022 May 25.
5
Perforant path synaptic loss correlates with cognitive impairment and Alzheimer's disease in the oldest-old.穿通通路突触丧失与高龄老人的认知障碍和阿尔茨海默病相关。
Brain. 2014 Sep;137(Pt 9):2578-87. doi: 10.1093/brain/awu190. Epub 2014 Jul 9.
6
Vertical Graphene-Based Printed Electrochemical Biosensor for Simultaneous Detection of Four Alzheimer's Disease Blood Biomarkers.基于垂直石墨烯的印刷电化学生物传感器用于同时检测四种阿尔茨海默病血液生物标志物。
Biosensors (Basel). 2023 Jul 25;13(8):758. doi: 10.3390/bios13080758.
7
Blood phosphorylated tau 181 as a biomarker for Alzheimer's disease: a diagnostic performance and prediction modelling study using data from four prospective cohorts.血液磷酸化 tau 181 作为阿尔茨海默病的生物标志物：使用来自四个前瞻性队列的数据进行的诊断性能和预测模型研究。
Lancet Neurol. 2020 May;19(5):422-433. doi: 10.1016/S1474-4422(20)30071-5.
8
Towards early diagnosis of Alzheimer's disease: advances in immune-related blood biomarkers and computational approaches.迈向阿尔茨海默病的早期诊断：免疫相关血液生物标志物和计算方法的进展。
Front Immunol. 2024 Apr 23;15:1343900. doi: 10.3389/fimmu.2024.1343900. eCollection 2024.
9
Effects of kidney function, serum albumin and hemoglobin on dementia severity in the oldest old people with newly diagnosed Alzheimer's disease in a residential aged care facility: a cross-sectional study.肾功能、血清白蛋白和血红蛋白对居住在养老院的新诊断为阿尔茨海默病的高龄老人痴呆严重程度的影响：一项横断面研究。
BMC Geriatr. 2020 Oct 7;20(1):391. doi: 10.1186/s12877-020-01789-0.
10
Resilience to cognitive impairment in the oldest-old: design of the EMIF-AD 90+ study.最年长老年人认知障碍的恢复力：EMIF-AD90+ 研究的设计。
BMC Geriatr. 2018 Nov 26;18(1):289. doi: 10.1186/s12877-018-0984-z.
引用本文的文献
1
Plasma phosphorylated tau 217 and amyloid‑β 42/40 for amyloid risk in subgroups.血浆磷酸化tau 217和淀粉样蛋白β 42/40用于亚组中的淀粉样蛋白风险评估
Alzheimers Res Ther. 2025 Aug 7;17(1):184. doi: 10.1186/s13195-025-01826-3.
本文引用的文献
1
Prognostic value of Alzheimer's disease plasma biomarkers in the oldest-old: a prospective primary care-based study.阿尔茨海默病血浆生物标志物在高龄老人中的预后价值：一项基于初级保健的前瞻性研究。
Lancet Reg Health Eur. 2024 Aug 16;45:101030. doi: 10.1016/j.lanepe.2024.101030. eCollection 2024 Oct.
2
Blood Biomarkers to Detect Alzheimer Disease in Primary Care and Secondary Care.用于在初级保健和二级保健中检测阿尔茨海默病的血液生物标志物。
JAMA. 2024 Oct 15;332(15):1245-1257. doi: 10.1001/jama.2024.13855.
3
Blood biomarkers for Alzheimer's disease in clinical practice and trials.阿尔茨海默病的临床实践和试验中的血液生物标志物。
Nat Aging. 2023 May;3(5):506-519. doi: 10.1038/s43587-023-00403-3. Epub 2023 May 18.
4
Differential roles of Aβ42/40, p-tau231 and p-tau217 for Alzheimer's trial selection and disease monitoring.Aβ42/40、p-tau231 和 p-tau217 在阿尔茨海默病临床试验选择和疾病监测中的作用差异。
Nat Med. 2022 Dec;28(12):2555-2562. doi: 10.1038/s41591-022-02074-w. Epub 2022 Dec 1.
5
Plasma and CSF biomarkers in a memory clinic: Head-to-head comparison of phosphorylated tau immunoassays.在记忆诊所中进行的血浆和脑脊液生物标志物检测：磷酸化tau 免疫分析的头对头比较。
Alzheimers Dement. 2023 May;19(5):1913-1924. doi: 10.1002/alz.12841. Epub 2022 Nov 12.
6
Head-to-head comparison of 10 plasma phospho-tau assays in prodromal Alzheimer's disease.在阿尔茨海默病前驱期，对 10 种血浆磷酸化 tau 检测方法进行头对头比较。
Brain. 2023 Apr 19;146(4):1592-1601. doi: 10.1093/brain/awac333.
7
Plasma p-tau231 and p-tau217 as state markers of amyloid-β pathology in preclinical Alzheimer's disease.血浆 p-tau231 和 p-tau217 作为临床前阿尔茨海默病淀粉样β病理的状态标志物。
Nat Med. 2022 Sep;28(9):1797-1801. doi: 10.1038/s41591-022-01925-w. Epub 2022 Aug 11.
8
Head-to-Head Comparison of 8 Plasma Amyloid-β 42/40 Assays in Alzheimer Disease.阿尔茨海默病中 8 种血浆淀粉样蛋白β 42/40 分析物的对头比较。
JAMA Neurol. 2021 Nov 1;78(11):1375-1382. doi: 10.1001/jamaneurol.2021.3180.
9
Comparison of Plasma Phosphorylated Tau Species With Amyloid and Tau Positron Emission Tomography, Neurodegeneration, Vascular Pathology, and Cognitive Outcomes.血浆磷酸化tau 种与淀粉样蛋白和 tau 正电子发射断层扫描、神经退行性变、血管病理学以及认知结果的比较。
JAMA Neurol. 2021 Sep 1;78(9):1108-1117. doi: 10.1001/jamaneurol.2021.2293.
Zotero 插件